{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:01:55Z","timestamp":1791838915519,"version":"4.3.4"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-04258-z","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T12:37:23Z","timestamp":1747226243000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study"],"prefix":"10.1007","volume":"317","author":[{"given":"Jasmine","family":"Levine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahib K","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Maltese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Adalsteinsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Talia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Ungar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"4258_CR1","doi-asserted-by":"publisher","unstructured":"Xing L, Dai Z, Jabbari A et al (Sep 2014) Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK Inhibition. Nat Med 20(9):1043\u20131049. https:\/\/doi.org\/10.1038\/nm.3645","DOI":"10.1038\/nm.3645"},{"issue":"6","key":"4258_CR2","doi-asserted-by":"publisher","first-page":"e2320351","DOI":"10.1001\/jamanetworkopen.2023.20351","volume":"6","author":"M Liu","year":"2023","unstructured":"Liu M, Gao Y, Yuan Y et al (2023) Janus kinase inhibitors for alopecia areata. JAMA Netw Open 6(6):e2320351. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.20351","journal-title":"JAMA Netw Open"},{"issue":"8","key":"4258_CR3","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1136\/ard-2023-224049","volume":"82","author":"MD Russell","year":"2023","unstructured":"Russell MD, Stovin C, Alveyn E et al (2023) JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications. Ann Rheum Dis 82(8):1059\u20131067. https:\/\/doi.org\/10.1136\/ard-2023-224049","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"4258_CR4","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1002\/cam4.1448","volume":"7","author":"CC Chen","year":"2018","unstructured":"Chen CC, Chang YT, Liu HN, Chen YJ (2018) Cancer risk in patients with alopecia areata: a nationwide population-based matched cohort study. Cancer Med 7(5):2153\u20132159. https:\/\/doi.org\/10.1002\/cam4.1448","journal-title":"Cancer Med"},{"key":"4258_CR5","doi-asserted-by":"publisher","unstructured":"Kridin K, Laufer-Britva R, Jimenez F, Cohen AD, Kaplan B, Lyakhovitsky A (2024) Alopecia areata and malignancies: uncertainties clarified by a large-scale population-based study. Arch Dermatol Res 316(10). https:\/\/doi.org\/10.1007\/s00403-024-03385-3","DOI":"10.1007\/s00403-024-03385-3"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04258-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-04258-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04258-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T12:37:24Z","timestamp":1747226244000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-04258-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":5,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4258"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-04258-z","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"12 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JT has served as consultant for Abbvie, Arcutis Biotherapeutics, Bristol Myers Squibb, Calliditas Therapeutics, J&J, LEO Pharma, Primus Pharmaceuticals, Sanofi Genzyme, Stifel Financial and UCB. NG is an employee of Mount Sinai and has served as a consultant for Almirall, Daiichi Sankyo, and Primus Pharmaceuticals. BU is an employee of Mount Sinai and has received research funds (grants paid to the institution) from: Bristol Myers Squibb, Incyte, Rapt Therapeutics, Pfizer, and Sanofi. He is also a consultant for AbbVie, Arcutis Biotherapeutics, Bristol Myers Squibb, Botanix Pharmaceuticals, Castle Biosciences, Fresenius Kabi, Galderma, J&J, Leo Pharma, Lilly, Pfizer, Primus Pharmaceuticals, Sanofi, and UCB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}},{"value":"This study was exempt from Mount Sinai Institutional Review Board oversight because it exclusively used de-identified data from patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB approval"}}],"article-number":"757"}}